The role of PSA density in the MRI pathway for prostate cancer diagnostics
- PMID: 35882951
- PMCID: PMC10449618
- DOI: 10.1038/s41391-022-00579-6
The role of PSA density in the MRI pathway for prostate cancer diagnostics
Erratum in
-
Correction to: The role of PSA density in the MRI pathway for prostate cancer diagnostics.Prostate Cancer Prostatic Dis. 2023 Dec;26(4):810. doi: 10.1038/s41391-023-00664-4. Prostate Cancer Prostatic Dis. 2023. PMID: 37012330 Free PMC article. No abstract available.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2021;79:243–62. doi: 10.1016/j.eururo.2020.09.042. - DOI - PubMed
-
- Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, PROMIS study group et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815–22. doi: 10.1016/S0140-6736(16)32401-1. - DOI - PubMed
-
- Rouvière O, Puech P, Renard-Penna R, Claudon M, Roy C, Mège-Lechevallier F, MRI-FIRST Investigators et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20:100–9. doi: 10.1016/S1470-2045(18)30569-2. - DOI - PubMed
-
- Frisbie JW, Van Besien AJ, Lee A, Xu L, Wang S, Choksi A et al. PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer. Prostate Cancer Prostatic Dis. 2022. 10.1038/s41391-022-00549-y. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous